Prot #B7451005: A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety and Efficacy of PF-04965842 in Subjects with Moderate to Severe Psoriasis

  • Gordon, Kenneth B (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/28/153/28/18

Funding

  • inVentiv Health Clinical (Prot #B7451005)
  • Pfizer Inc. (Prot #B7451005)